Kenacort-A 10

País: Nueva Zelanda

Idioma: inglés

Fuente: Medsafe (Medicines Safety Authority)

Ingredientes activos:

Triamcinolone acetonide 10 mg/mL; Triamcinolone acetonide 10 mg/mL

Disponible desde:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

Designación común internacional (DCI):

Triamcinolone acetonide 10 mg/mL

Dosis:

10 mg/mL

formulario farmacéutico:

Suspension for injection

Composición:

Active: Triamcinolone acetonide 10 mg/mL Excipient: Benzyl alcohol Carmellose sodium Polysorbate 80 Sodium chloride Water for injection Active: Triamcinolone acetonide 10 mg/mL Excipient: Benzyl alcohol Carmellose sodium Polysorbate 80 Sodium chloride Water for injection

Unidades en paquete:

Ampoule, glass, 5x1ml, 5 mL

clase:

Prescription

tipo de receta:

Prescription

Fabricado por:

Crystal Pharma SA

indicaciones terapéuticas:

Intra-articular: Kenacort-A 10 Injection is indicated for intra-articular or intra-synovial administration, and for injections into tendon sheaths, as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: synovitis of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis, acute gouty arthritis, epicondylitis, acute nonspecific tenosynovitis, post-traumatic osteoarthritis.

Resumen del producto:

Package - Contents - Shelf Life: Ampoule, glass, 5x1ml - 5 mL - 36 months from date of manufacture stored at or below 30°C

Fecha de autorización:

1969-12-31

Información para el usuario

NEW ZEALAND CONSUMER MEDICINE INFORMATION 
KENACORT
®
-A 10 
_triamcinolone acetonide  _

WHAT IS IN THIS LEAFLET 

This leaflet answers some common questions about KENACORT-A 10. It
does not contain all the available 
information. It does not take the place of talking to your doctor or
pharmacist. 

All medicines have risks and benefits. Your doctor has weighed the
risks of you taking KENACORT-A 10 
against the benefits they expect it will have for you. 

IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR
OR PHARMACIST. 

KEEP THIS LEAFLET. You may need to read it again. 

WHAT IS KENACORT-A 10

USED FOR 
_ _
KENACORT-A 10 is used to treat allergic diseases, bad skin problems or
arthritis.  To treat these problems 
it is injected deep into a muscle.  From the muscle it is slowly
absorbed into the blood and carried by the 
blood to all parts of the body. 

KENACORT-A 10 can also be used to treat painful muscles, joints
or tendons by injecting directly into the 
painful site. 

KENACORT-A 10 can also be used to treat inflammatory skin lesions,
psoriatic plaques & hair loss by 
injecting directly into the lesion or by sub-cutaneous injection.  

However, your doctor may have prescribed KENACORT-A 10 for another
purpose.  Ask your doctor if you 
have any questions about why KENACORT-A 10 has been prescribed for
you. 

The way that KENACORT-A 10 works is complicated.  Put simply,
KENACORT-A 10 suppresses 
inflammation and swelling and relieves pain.  However, it does
not cure the underlying problem.

KENACORT-A 10 is available only with a doctor’s prescription. 

KENACORT-A 10 is NOT suitable for intravenous, intramuscular or
intraocular use. KENACORT-A 10 is 
not suitable for injection into the nasal turbinates or intralesional
injection about the head. 

KENACORT-A 10 is NOT recommended for use in children under the age of
six. 

KENACORT-A 10 is NOT for use in newborn or premature infants 
�

Ficha técnica

KENACORT-A 10 – Data Sheet
Page 1 of 13
NEW ZEALAND DATA SHEET
1.
PRODUCT NAME
KENACORT-A 10 suspension for injection
_ _
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
KENACORT-A 10 contains 10 mg/1 mL triamcinolone acetonide.
For the list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
KENACORT-A 10 is a sterile, aqueous opaque white suspension.
4.
CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
_INTRA-ARTICULAR: _
Kenacort-A 10 Injection is indicated for intra-articular or
intra-synovial administration,
and for injections into tendon sheaths, as adjunctive therapy for
short-term
administration (to tide the patient over an acute episode or
exacerbation) in: synovitis
of osteoarthritis, rheumatoid arthritis, acute and subacute bursitis,
acute gouty
arthritis, epicondylitis, acute nonspecific tenosynovitis,
post-traumatic osteoarthritis.
_INTRADERMAL: _
Intralesional administration of Kenacort-A 10 Injection is indicated
for the treatment
of keloids, discoid lupus erythematous, necrobiosis lipoidica
diabeticorum, alopecia
areata, and localised hypertrophic, infiltrated, inflammatory lesions
of: lichen planus,
psoriatic plaques, granuloma annulare, and lichen simplex chronicus
(neurodermatitis). Kenacort-A 10 Injection also may be useful in
cystic tumours of an
aponeurosis or tendon (ganglia).
4.2 DOSE AND METHOD OF ADMINISTRATION
Kenacort-A 10 is suitable for intradermal, intra-articular and
intra-synovial injection
and for injection into tendon sheaths. This formulation is not
suitable for intravenous,
intramuscular or intraocular use.
This preparation contains benzyl alcohol. Not for use in newborn or
premature
infants (see section 4.4 Special Warnings and precautions for use, Use
in children).
_GENERAL: _
The initial dosage should be maintained or adjusted until a
satisfactory response is
noted. If after a reasonable period of time there is a lack of
satisfactory clinical
KENACORT-A 10 – Data Sheet
Page 2 of 13
response, Kenacort-A 10 Injection should be discontinued and the
patient transferred
to oth